US9303033, H19, Table 33A, Compound 131

ID: ALA3953661

Chembl Id: CHEMBL3953661

PubChem CID: 137290263

Max Phase: Preclinical

Molecular Formula: C23H20N8O2

Molecular Weight: 440.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(=O)/C(=C/c2cnn3c(NC4CC4)nc(NCc4cccc5ccccc45)nc23)N1

Standard InChI:  InChI=1S/C23H20N8O2/c32-20-18(27-23(33)29-20)10-15-12-25-31-19(15)28-21(30-22(31)26-16-8-9-16)24-11-14-6-3-5-13-4-1-2-7-17(13)14/h1-7,10,12,16H,8-9,11H2,(H2,24,26,28,30)(H2,27,29,32,33)/b18-10-

Standard InChI Key:  DMUMUGAVVTZORI-ZDLGFXPLSA-N

Alternative Forms

  1. Parent:

    ALA3953661

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase II alpha/beta (1504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2B Tbio Casein kinase II beta (977 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 440.47Molecular Weight (Monoisotopic): 440.1709AlogP: 2.64#Rotatable Bonds: 6
Polar Surface Area: 125.34Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.24CX Basic pKa: 2.31CX LogP: 2.16CX LogD: 1.78
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -1.09

References

1.  (2016)  Pyrazolopyrimidines and related heterocycles as CK2 inhibitors, 

Source

Source(1):